Intervention
graft versus host disease prophylaxis/therapy
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownDonor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantNCT00361049 · 2004-09-01
COMPLETEDPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationNCT00003538 · 1997-03-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED2
Phase mix
NA1
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.